Search: nasdaq:imvt


SEARCH RESULTS FOR "NASDAQ:IMVT" NEWS

Cantor Fitzgerald Issues Multiple "Strong-Buy" Ratings

Cantor Fitzgerald Issues Multiple "Strong-Buy" Ratings
19

Cantor Fitzgerald has issued "strong-buy" ratings for multiple stocks, including Immunovant, Ardelyx, Kura Oncology, and Mesoblast. Meanwhile, Bank of America adjusts price targets for Gilead Sciences and Immunovant. Read more...

MOST VIEWED

Gaza Attack Kills 9 Amid Ceasefire Talks

Gaza Attack Kills 9 Amid Ceasefire Talks

8888
Cohen Backlash & Tebow Baby News

Cohen Backlash & Tebow Baby News

5805
Entertainment Buzz: New Shows and Dobrik's Fortune

Entertainment Buzz: New Shows and Dobrik's Fortune

1923
Hamšík's League Debut & Other Sports News

Hamšík's League Debut & Other Sports News

1729